CRMD

$0.00

(

0.00%

)
Quote details

stock

CorMedix Inc

NASDAQ | CRMD

11.65

USD

$0.00

(

0.00%

)

At Close (As of Oct 21, 2025)

$949.19M

Market Cap

15.59

P/E Ratio

0.78

EPS

$17.43

52 Week High

$5.60

52 Week Low

HEALTHCARE

Sector

CRMD Chart

Recent Chart
Price Action

CRMD Technicals

Tags:

CRMD Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $40M
Total Revenue $43M
Cost Of Revenue $3.2M
Costof Goods And Services Sold $3.2M
Operating Income -$22M
Selling General And Administrative $30M
Research And Development $3.9M
Operating Expenses $63M
Investment Income Net -
Net Interest Income $2.5M
Interest Income $2.6M
Interest Expense $36K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $457K
Income Before Tax -$19M
Income Tax Expense -$1.4M
Interest And Debt Expense -
Net Income From Continuing Operations -$18M
Comprehensive Income Net Of Tax -
Ebit -$19M
Ebitda -$19M
Net Income -$18M

Revenue & Profitability

Earnings Performance

CRMD Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $119M
Total Current Assets $115M
Cash And Cash Equivalents At Carrying Value $41M
Cash And Short Term Investments $41M
Inventory $7.6M
Current Net Receivables $52M
Total Non Current Assets $4.3M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $1.8M
Intangible Assets Excluding Goodwill $1.8M
Goodwill $1.8B
Investments -
Long Term Investments -
Short Term Investments $11M
Other Current Assets $3.6M
Other Non Current Assets -
Total Liabilities $34M
Total Current Liabilities $34M
Current Accounts Payable $1.7M
Deferred Revenue -
Current Debt -
Short Term Debt $168K
Total Non Current Liabilities $349K
Capital Lease Obligations $517K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $517K
Other Current Liabilities $32M
Other Non Current Liabilities -
Total Shareholder Equity $85M
Treasury Stock -
Retained Earnings -$340M
Common Stock $64K
Common Stock Shares Outstanding $59M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$51M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $310K
Capital Expenditures $116K
Change In Receivables -
Change In Inventory -$5.5M
Profit Loss -
Cashflow From Investment $21M
Cashflow From Financing $26M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$18M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $40M
Total Revenue $43M
Cost Of Revenue $3.2M
Costof Goods And Services Sold $3.2M
Operating Income -$22M
Selling General And Administrative $30M
Research And Development $3.9M
Operating Expenses $63M
Investment Income Net -
Net Interest Income $2.5M
Interest Income $2.6M
Interest Expense $36K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $457K
Income Before Tax -$19M
Income Tax Expense -$1.4M
Interest And Debt Expense -
Net Income From Continuing Operations -$18M
Comprehensive Income Net Of Tax -
Ebit -$19M
Ebitda -$19M
Net Income -$18M

CRMD News

CRMD Profile

CorMedix Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

CorMedix Inc. is a biopharmaceutical company headquartered in Berkeley Heights, New Jersey, specializing in the development and commercialization of innovative therapies for infectious and inflammatory diseases. The company is committed to addressing critical unmet medical needs, particularly in infection control and inflammatory conditions. With a robust pipeline of products aimed at improving patient outcomes, CorMedix is strategically positioned to impact the global healthcare landscape significantly. Its focus on innovative solutions ensures relevance in an increasingly competitive market, appealing to institutional investors looking for growth in healthcare innovation.

BYND
+146.25%
$3.62
VHAI
0.00%
$0.00
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+28.69%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
ADAP
-17.62%
$0.04
BURU
-14.84%
$0.28
T
-0.19%
$26.05
AIRE
+61.36%
$0.72
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.24%
$13.39
DVLT
+4.54%
$2.52
IBIO
+24.30%
$1.11
RIG
+0.60%
$3.31
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
ETHD
-0.53%
$3.73
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
GRAB
-1.23%
$5.60
AMZN
+2.56%
$222.03
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
LAES
-5.86%
$6.10
ACHR
-4.75%
$11.41
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
VALE
-1.14%
$11.27
BTBT
-8.29%
$3.87
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
IREN
-6.79%
$55.19
RMBL
+60.50%
$3.21
DCGO
+24.16%
$1.49
HAL
+11.58%
$25.24
MARA
-3.18%
$20.07
BBD
-2.21%
$3.30
ADD
-25.47%
$0.05
AAL
+1.47%
$12.35
GPUS
-7.57%
$0.36
NOK
-2.27%
$5.58
DFLI
-3.96%
$1.21
CLSK
-7.62%
$18.84
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
KO
+4.06%
$71.22
PBR
-1.11%
$11.56
SNAP
+1.55%
$7.85
AMC
+3.61%
$2.87
SMR
-13.20%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
CUTR
-10.19%
$0.09
HIMS
-3.89%
$49.36
ONDS
-7.46%
$7.19
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
EPWK
-8.71%
$0.07
ETWO
0.00%
$3.30
APLD
-9.35%
$32.54
BULL
-2.96%
$11.14
IONQ
-0.73%
$59.50
RGTZ
+15.11%
$15.61
WTO
+2.93%
$0.06
KVUE
-0.20%
$14.93
AG
-11.21%
$12.75
INFY
+2.95%
$17.41
CORZ
+2.23%
$19.23
BYND
+146.25%
$3.62
VHAI
0.00%
$0.00
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+28.69%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
ADAP
-17.62%
$0.04
BURU
-14.84%
$0.28
T
-0.19%
$26.05
AIRE
+61.36%
$0.72
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.24%
$13.39
DVLT
+4.54%
$2.52
IBIO
+24.30%
$1.11
RIG
+0.60%
$3.31
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
ETHD
-0.53%
$3.73
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
GRAB
-1.23%
$5.60
AMZN
+2.56%
$222.03
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
LAES
-5.86%
$6.10
ACHR
-4.75%
$11.41
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
VALE
-1.14%
$11.27
BTBT
-8.29%
$3.87
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
IREN
-6.79%
$55.19
RMBL
+60.50%
$3.21
DCGO
+24.16%
$1.49
HAL
+11.58%
$25.24
MARA
-3.18%
$20.07
BBD
-2.21%
$3.30
ADD
-25.47%
$0.05
AAL
+1.47%
$12.35
GPUS
-7.57%
$0.36
NOK
-2.27%
$5.58
DFLI
-3.96%
$1.21
CLSK
-7.62%
$18.84
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
KO
+4.06%
$71.22
PBR
-1.11%
$11.56
SNAP
+1.55%
$7.85
AMC
+3.61%
$2.87
SMR
-13.20%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
CUTR
-10.19%
$0.09
HIMS
-3.89%
$49.36
ONDS
-7.46%
$7.19
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
EPWK
-8.71%
$0.07
ETWO
0.00%
$3.30
APLD
-9.35%
$32.54
BULL
-2.96%
$11.14
IONQ
-0.73%
$59.50
RGTZ
+15.11%
$15.61
WTO
+2.93%
$0.06
KVUE
-0.20%
$14.93
AG
-11.21%
$12.75
INFY
+2.95%
$17.41
CORZ
+2.23%
$19.23

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.